Organization | Jincheng People’s Hospital

Jincheng People’s Hospital Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial

2018

NCT03406819

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Jincheng People’s Hospital | JIN CHENG PEOPLE'S HOSPITAL

Active Ingredients

Drugs in Phase 4 Trials (1)

interferon alpha-2b (Intron-A) (1 trial)

Drugs in Other Trials (4)

heparin (liquaemin) (2 trials)

nitroprusside (nipride) (2 trials)

sodium chloride (2 trials)

tirofiban (aggrastat) (2 trials)

Indications

Overview

Highest Phase: Phase 4
# of Trials: 3
# of Trial APIs: 5